19
Fri, Jul
60 New Articles

Kondracki Celej, Rymarz Zdort Maruta, and BCGL Advise on Sale of Telemedi to Mavie Next

Kondracki Celej, Rymarz Zdort Maruta, and BCGL Advise on Sale of Telemedi to Mavie Next

Poland
Tools
Typography
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

Kondracki Celej has advised Telemedi founder Pawel Sieczkiewicz and the company’s investors on its sale to Mavie Next. Rymarz Zdort Maruta advised Mavie Next. Balicki Czekanski Gryglewski Lewczuk advised Telemedi investor Adamed Pharma on the sale.

Telemedi is a digital health platform and telehealth provider in Poland.

Mavie Next is an Austria-based healthcare provider.

Back in 2021, Kondracki Celej advised Telemedi on its series A investment round which raised USD 6.6 million (as reported by CEE Legal Matters on February 9, 2021). The round's investors included Flashpoint Venture Capital, UNIQA Ventures, PKO Bank Polski, Black Pearls VC, and Adamed Pharma.

The Kondracki Celej team included Partner Rafal Celej, Senior Associate Arek Klejnowski, Associate Monika Twerdochlib, and Paralegal Gabriela Lewicka.

The Rymarz Zdort Maruta team included Partner Jacek Zawadzki, Counsel Monika Gieraltowska-Karpowicz, Senior Associates Malgorzata Derus and Weronika Papucewicz, and Associates Patrycja Gliwka, Agnieszka Jablonska-Zachwieja, Justyna Niezgoda, and Alicja Mikos.

The BCGL team included Partner Jacek Balicki.